← Azimuth Daily
Capturing data…
Capturing data…
THU, 12 NOV · 87 ITEMS
"Blood-brain barrier blocks protective proteins in early Alzheimer's" — Nature (current) · Science & Medicine
In early Alzheimer's disease, the (BBB) becomes dysfunctional and actively blocks protective proteins from entering the brain, worsening neurodegeneration. New research identifies accumulation in the BBB—especially in carriers—as a key driver of this barrier breakdown, and shows that targeting fibronectin can restore barrier function and allow protective factors through.
The claim is drawn from a Nature news article (doi:10.1038/d41586-026-03655-2) that summarizes a peer-reviewed study published in Nature Aging (doi:10.1038/s43587-026-01204-0). The news piece is a secondary source, but the underlying research is primary and credible. The headline simplifies a complex mechanism, but the core finding—that fibronectin-driven BBB dysfunction impedes protective proteins—is well-supported by the study.
Genuinely new: the underlying study and news coverage appeared in September 2026.